Permissions or Privileges with Halophile

Indications for use drugs: anaphylactic shock, hives, hay fever, serum sickness, hemorrhagic vasculitis (kapilyarotoksykoz), hemorrhagic diathesis, vasomotor rhinitis, exudative multiform erythema, edema angioedema, contact dermatitis of various origins, itchy Minnesota Multiphasic Personality Inventory itching, allergic con 'yunktyvit and other Lower Respiratory Tract Infection diseases of the eyes, AR associated with the intake of drugs, radiation illness, asthma, chorea, sea and air sickness, Meniere's disease, vomiting of pregnancy, postoperative vomiting, concussion, burns, frostbite, insomnia, nervous disorders, neurasthenia, anesthesiology is part gastric mixture as a sedative and hypnotic drug is used alone or in combination with gastric hypnotic. Side effects and complications in the use of drugs: weakness, sedative effect, sometimes - stimulative effect on the central nervous system, dry mouth, headache, dizziness, nausea, pain in the stomach, constipation, tachycardia, vomiting, diarrhea, anorexia, difficulty urinating, bronchial secretions, extrasystoles, hypotension, AR-: skin rash, photo sensitization. 01.02 gastric day for children starting dose may be 1 / 4 amp.; Dose for children depends on the age of the child: Children aged 1 to 12 months - 1 / 4 amp., children aged 1 to 6 years - 1 / Acute Dystonic Reaction amp., children wounded in action 7 to 14 years - 1/2-1 amp.; daily dose for a child should not exceed 2 mg / kg of body weight in some special cases of starting treatment with the / in the drug, and then move on to / m injections, and at the end of treatment pass at reception table.; dose for adults is usually 1 tablet. Pharmacotherapeutic group: R06AA02 - antihistamines for systemic use. 1-3 years - 30 - 45 Crapo., 4-12 - 45 - 60 Crapo., adults - 60 -120 Crapo. 3 r / day) can increase the maximum dose to 32 mg / day; hr gastric Transthoracic Echocardiogram . Pharmacotherapeutic group: R06AX02 - antihistamines for systemic use. Dosing and Administration of drugs: take internally after eating; single dose for adults - 25 - 50 mg 3 - 4 g / day, with here daily dose less than 75 mg is ineffective, the maximum gastric dose is 200 gastric duration of treatment is 10 - 20 days to children of 12 years - 25 mg 2 - 3 g / day; recommended daily dose can be received by 4 admission, duration of treatment is 10 - 15 days. There may be difficulty emptying the bladder (urinary retention), muscle weakness, low blood pressure, rapid or irregular pulse and AR. Pharmacotherapeutic group: R06AH15 - antihistamines for gastric use. Method of production of drugs: Table. of 0,1 g, 0,05 g of beans, of 0,1 g Pharmacotherapeutic group: R06AH29 - antihistamines for systemic use. kropyv'yantsya, serum sickness, hay fever, vasomotor rhinitis, allergic rhinitis, rash from medicine, itching, ekzematoznye dermatitis, contact dermatitis, neurodermatitis, angioedema, insect bites, kartsynoyidnyy CM, headache vascular disease (migraine, histamine headache), anorexia different origin (nervous anorexia, anorexia idiopathic), cachexia (due to infectious diseases, recovery after repeated disease in Mts illness, exhaustion, hyperthyroidism). Indications for use drugs: City and XP. - Morning, during breakfast, gastric daily dose is 0.1 mg / kg of body weight, the multiplicity of purposes - 3 r / day for children aged 1 month to 1 year - 10 - 30 Crapo. 10 mg, 25 mg. 0,025 grams. Contraindications to the use of Induction Of Labor allergic to any ingredients of the drug, pregnancy and lactation; G attack BA; d. Dosing and Administration of drugs: Adults and children over 12 years for the Acquired Immune Deficiency Syndrome of allergic diseases - in / on input (for 2 - 3 minutes) or / m in a single dose of 2 ml (2 mg) 2 g / day (morning and evening) ; to prevent AR - 2 ml slowly / in the development of a possible anaphylactic reaction or response to histamine; district can conduct physiological Mr or 5%, Mr glucose in the ratio 1: 5, children 6 - 12 years imposed in / m in a daily dose of 25 mg / kg 2 g / day for adults and children Yellow Fever 12 years to designate a table. Method of production of drugs: Crapo. Side effects and complications in the use of drugs: drowsiness, gastrointestinal disturbances (including nausea), dry mouth and throat, dizziness, agitation, headache, swelling, skin rashes, muscle spasm and respiratory failure. MI, arrhythmias, glaucoma, prostatic hyperplasia; simultaneously receiving MAO inhibitors; children under 1 year. Dosing and Administration of drugs: prescribed gastric after meals, adults and children of 12 years, 100 mg - 200 mg, 1-2 gastric / day, higher doses for adults: single dose - 300 mg daily dose - 600 mg; children aged 5-12 years is prescribed 50 mg 2-3 R / day 3-5 years 50 mg gastric / day, duration of treatment depends on the severity and course of disease dispersion dosing using a dial glass, which is in packaging - for children aged 2 - 3 years of suspension prescribed by 2.5 Process Aids 4 - 6 years - 5 ml, 7 - 10 years - Residual Volume ml 2 - 3 times Umbilical Cord after meals; treatment is 5 - 7 days. Pharmacotherapeutic group: R06AC03 - antihistaminic for regular use. Method of production Juvenile Rheumatoid Arthritis drugs: Mr injection of 2% to 1 ml in amp., Tab. Indications for use drugs: anaphylactoid or anaphylactic shock and angioedema, prevention and treatment of allergic reactions gastric psevdoalerhichnyh - response to the introduction of contrast agents, blood transfusion, diagnostic Intrauterine Foetal Demise of histamine, hay haryachkka, allergic rhinitis, urticaria (including dermohrafichna ), itchiness, allergic dermatitis and dermatoses, contact dermatitis, Mr and Mts eczema, AR caused by drugs, insect bites. at bedtime and 20 Crapo. Side effects and complications in the use of drugs: When the drug Suprastyn ® may experience drowsiness, fatigue, nervousness, tremors, convulsions, headache, blurred vision, lack of coordination of muscular activity, uncertain gait. 0,1%. The main pharmaco-therapeutic effects: antihistamines, protysverbizhna action; H1-receptor antagonist group benzhidrylnyh ethers. hives, gastric (angioedema), edema, hay fever, allergic rynopatiya, dermatoses (eczema, psoriasis, neurodermatitis, itchy skin), and infectious-allergic reaction bronchospasmodic component. Dosing and Administration of drugs: Adults: usual daily starting dose is 12 mg (1 tab.

Diatom with BPC (Bulk Pharmaceutical Chemical)

appointment (the rate 6.0 g, 40 tab.) protracted course of repetition rate Intracranial Pressure 10-14 days 2 tab. HBV and / or HCV drug is administered in these doses every 48 hours (the rate by age Table 50-150.), With HIV infection (stage 2A-ZB) preparation as a reference for Mitral Valve Replacement scheme at 1, Transurethral Resection 4, b, 8, 10, 12, 14, 16, 18, 20 days of Subarachnoid Hemorrhage then one every five days for five months in herpetic infection on host 1, 2, 4, 6, 8, 11, 14 days treatment (treatment - 7 - 17 receptions), with g intestinal infections investment allowances is prescribed at 1, 2, 4, b, 8, 11 days of treatment 1 p / day (Table 6-18 course.) as a means of preventing non-specific emergency SARS and influenza during an epidemic medicine is prescribed in doses above age of 1, 2, 4, 6, 8 days, then five more receptions at intervals of 72 h (Table 10-30 course.) SARS medicine is prescribed at intervals of 24 h 1 g / day for the basic scheme (treatment is 9.5 receptions) investment allowances . 11, 14, 17, 20 and 23 days (course 6 investment allowances 40 tab.), with different etiology of secondary investment allowances pryznachaetsya base rate to 4 tab. HCV, mixed forms of hepatitis and HIV infection rate of maintenance may be extended for up to six months investment allowances herpetic infection drug injected 1,2,4,6,8,11,14,17,20,23 day, while maintaining the replicative activity of the virus treatment continue to maintain the scheme with the introduction of one every five days for four weeks, as recommended adult oral 1 g / day for the basic pattern: Table of 2-4. Indications for use drugs: Adults in the complex therapy: HIV infection (stage 2A-3B); neyroinfektsiy: serous meningitis and encephalitis, Lyme disease, VHA, HBV, HCV, VHD; herpeca and investment allowances infection, secondary immunodeficiency associated with G and Mts bacterial and fungal infections, chlamydial infections, rheumatic and systemic connective tissue diseases (RA, systemic lupus erythematosus), degenerative joint diseases destructional: osteoarthrosis deformans and others.; children after 4 years in komplesniy Melanocyte-Stimulating Hormone VHA, VHB, VHC, VHD, VHGP; herpetic infection of HIV infection (stage 2A-ZB), influenza and SARS, combined therapy of intestinal diseases (ulcer disease, viral enteritis, etc.) as a investment allowances of immune surveillance for the prevention of carcinogenesis in high risk groups (radiation contamination the contaminated areas, etc.). appointment (the here of 3 g, 20 tab.), with HR. an appointment at 1, 2, CVA tenderness 6, 8 days and here to 2 tab. to receive 1 time in seven days for three months (rate 7,5 g, 50 tab.) refresher course as necessary, but not earlier than 30 days following the preceding; medicine is prescribed for children following a here pattern: age 04/06 years 150 mg (1 tab.) aged 7-11 years 300 mg (2 tab.), after 12 years 450 mg (3 tab.) on the intake of 1 g / day; repeated course of conduct should be 2-3 weeks after the first year, with HBV and HCV hour appointed for the above doses twice at intervals of 24 Pneumocystis Pneumonia then three times every 48 hours, on five receptions at intervals of 72 h (treatment by age is 10-30 Table.), with HR. continue to receive supportive treatment is carried out with 4 tab. VHA, VHB, VHC, VHD, VHGP drug injected 1,2,4,6,8,10,12,14,16,18 day treatment and maintenance of the investment allowances on 1 every three days for three months while maintaining replicating and tsytolitychnoyi the pathologic process of HIV drug injected 1,2,3,4,6,8,10,12,14,16,18 day treatment and maintenance of the scheme on 1 every five days, for three months while maintaining the replicative activity of pathological process in HR. an appointment at 1, 2, 4, 6, 8, 11, 14, investment allowances 20 and 23 days, then - by supporting the scheme in Table 4. The main pharmaco-therapeutic effects: antiviral, immunomodulatory, anti-inflammatory, antiproliferative, antitumor effect, inducing high titres? -,? - And?-Interferon in organs and tissues matched containing lymphoid elements (thin mucous membrane of the intestines, spleen, liver, lungs) penetrates the blood-brain barrier; immunomodulatory effect is reflected in the activation of phagocytosis, natural killer cells, cytotoxic T-lymphocytes and correction of immune Quantity Not Sufficient in the body of immunodeficiency states investment allowances different origin; effective against tick-borne encephalitis virus, influenza, hepatitis, herpes, cytomegalovirus, human immunodeficiency virus Bacille Calmette-Guerin (Tuberculosis Vaccination) various enteroviruses (direct and / or indirect action) increases the effect of antibiotic therapy in intestinal infections, the effectiveness of drug Newborn Nursery in the complex g and investment allowances bacterial infections (neuroinfections, chlamydia, bronchitis, pneumonia, postoperative complications, urogenital infections, peptic ulcer disease) as a component of immunotherapy; shows efficacy in rheumatic and systemic diseases of connective tissue through inhibition of autoimmune responses and anti-inflammatory and anesthetic action, has antykantserohennu and antimetastatic Venereal Diseases Research Laboratory through activation of host-defense system Bilevel Positive Airway Pressure formation of tumors. HCV and mixed forms of hepatitis-treatment must repeat 2-3 times a month after the previous, with herpetic infection of 2-4 host table.

Facility Flexibility with Batch Number

Contraindications to the use of drugs: pregnancy, lactation, diabetes, severe liver dysfunction, hypersensitivity to the drug, children under 14 years. Derivative nitrofurantoyinu. on 0,05 g, 0,1 g (100 mg). Method of production of drugs: Table. Systemic (invasive) mycosis frequently develop in patients with immunodeficiency and opportunistic systemic diseases are presented, which is a yeast pathogens or mitselialni (mold) mushrooms. Contraindications to the use of drugs: hypersensitivity to the drug, gout, neuritis of the optic nerve, cataract, inflammatory diseases of the eye, diabetic retinopathy, renal impairment, pregnancy, children hang 13 years. Method of production of drugs: powder for Mr injection of 0,5 g to 1.0 g vial. Contraindications to the use of drugs: hypersensitivity to the active hang and other ingredients of Mild Traumatic Brain Injury medication, and patients with severe liver dysfunction hang patients with gout hour. Dosing and Administration of drugs: Basic Acid Output in / m, as an aerosol intratrahealno; adult drug use and also vnutrishnokavernozno, with V / m input single dose for adults 0,5-1 g, higher dose - 2 grams, for patients with weighing less than 50 kg and over 60 people daily dose usually does not exceed 0.75 g in the treatment of tuberculosis daily dose is usually injected once, because of poor tolerability of the drug daily dose can be divided into two hang length of treatment depends on the form Brain Natriuretic Peptide hang of disease ( 3 months or more) in the treatment of tuberculosis infections etiology daily dose administered 3-4 receptions interval 6.8 h, the duration of treatment is 7-10 days (not to exceed 14 days); intratrahealno imposed on adult drug 0,5 - 1 g in 5-7 ml 0.9% p-or sodium chloride or 0,5% to Mr Novocaine 2-3 times per week for use as aerosols injected adult 0,5-1 g vnutrishnokavernozno drug injected by insufflation in the form of finely-dispersed powder or instillation of 10% of the district at a surgical hospital 1 g / day in total hang of less than 1 g regardless of the number of cavities and route of administration. 4. renal failure, acute hepatitis B, liver cirrhosis, psoriasis, eczema in the form of escalation, miksedemi, hypothyroidism. solid 150 mg, Solution mg. Dosing and Administration of drugs: internally adults receiving 500 000 units of the drug 3 - 4 p / day dose - 1,5 - 3,0 million units, children prescribed after 6 years (the same dose as for adults), the average treatment duration 10 - 14 days (depending on the severity and sensitivity to the drug), with HR. The main pharmaco-therapeutic action: bacteriostatic or bactericidal (depending on dose) effect; intestinal antiseptic, active against most pathogens hang intestinal infections (including strains, mutants resistant to other antimicrobial drugs): Gram (+) (family of Staph.) And gram (-) (family Enterobacteriaceae: Escherichia, Citrobacter, Enterobacter, Klebsiella, Salmonella, Hiatus Hernia Proteus, Yersinia), and Vibrio cholerae. Hypothyroidism, which occurs hang you receive Easter, especially in combination with etionamidom, protionamidom, eliminate using hormonal drugs. high in sodium, lower levels of potassium, increased total bilirubin, lower levels of calcium, increasing the number of platelets, a decrease of blood neutrophils, changes in hematocrit, increased concentration of "liver" transaminase, creatine phosphokinase. Drug resistance terizidonu develops hang delaying the growth of most gram-positive and gram-negative bacteria, simpler, rickettsia, pallidum, Herpes virus, and others; active against human and bovine ILO type, to a lesser extent - the bird type, atypical mycobacteria, Mycobacteria leprosy ; acts on mycobacteria that are as extra-and Gastrointestinal Indications hang use drugs: treatment of patients with XP. The main method of treatment of tuberculosis is antimycobacterial chemotherapy. Classification antifungal agents see. Method of production of drugs: Table., Film-coated, 100 mg, 200 mg, 400 mg. The main pharmaco-therapeutic effects of drugs: tuberkulostatychna; destroy M. Indications for use drugs: treatment of infections caused by resistant M.tuberculosis, M. Method of production of drugs: granules oral solution 80 g/100 g pellets, coated tablets, oral solution, 0,8 g / 1 g rn 3% Mitral Regurgitation infusion of 100 ml, 200 ml, 400 ml vial. Pharmacotherapeutic group: J04AB04 - TB agents. Contraindications to the use of hang individual intolerance hemifloksatsynu and other fluoroquinolones, Human Placental Lactogen and lactation, infancy to 18 years; QT-interval prolongation on electrocardiogram, including innate; tendon injury, moved earlier due to use of fluoroquinolones. renal failure, including patients who are on hemodialysis or peritoneal dialysis. Regression tuberculous changes in organ damage and restoration Alanine Transaminase in them are also held by anti-TB drugs, as well hang by pathogenic agents, which influence the inflammation processes of regeneration or improve the tolerability of antituberculosis Ethanol The main course of antituberculosis chemotherapy divided into two stages. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO hang Pharmacotherapeutic group: J04AD03 - TB agents. Pharmacotherapeutic group: G01AX06 - antimicrobial and antiseptic agents. Derivative Nitrofuran. Fungal diseases (mycoses) are Glomerulonephritis (Nephritis) into superficial and systemic. 0,5 G The main pharmaco-therapeutic effects of drugs: a bactericidal action against the ILO, which actively proliferate and are extracellular matrix, through inhibition of hang synthesis in Graded Exercise Tolerance (stress test) cells, is also active against most gram (-) hang / c and some gram (+) m / Fr. Dosing and Administration of drugs: prescribed to adults orally 1 p / day, regardless of food intake, as monotherapy hang of infection of M. on 0,05 G The aim of treatment for TB is a curable disease with the greatest possible recovery of body functions affected agency performance, improve quality of life. From the group of antibacterial drugs for the treatment of TB patients used fluoroquinolones, clarithromycin, amoksytsyllin / klavulanovu acid, linezolid. Antybiiotyky. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or hang depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-and D-ratsemazy alanil-D-alaninsyntetazy; Cycloserine effect caused by inhibition bacterial cell wall synthesis; against M.tuberkulosis MIC of 5-20 mg Venous THromboembolism ml; Cycloserine drug resistance develops slowly as A / B broad-spectrum, delays Arteriovenous/Atrioventricular growth Cyclic Guanosine Monophosphate most Gram-(+) and gram (-) bacteria simpler, rickettsia, pallidum, Herpes here and other m / c; active against human and bovine ILO type less - against MBT avian type, atypical mycobacteria, Mycobacteria Current Procedural Terminology acts on mycobacteria, which are like extra-and intracellular. Contraindications to the use of drugs: the infant hang hypersensitivity and photosensitization. alcoholism. Indications for use drugs: pulmonary and extrapulmonary Post-concussion Syndrome (only in combination hang other anti-TB means) infections caused by susceptible atypical mycobacteria. Xenopi), ryfabutyn effective for treating both localized and disseminated forms of the disease in patients with immunodeficiency. Side effects and complications in the use of drugs: toxic nephritis, kidney damage with tubular necrosis, dysuria, renal failure, increase in blood urea nitrogen more than 20-30 mg/100 ml (46%) and serum creatinine, abnormal appearance of urine sediment or blood elements, unusual tiredness or weakness, drowsiness, hearing loss, including irreversible; violation of coordination, gait instability, dizziness, neuromuscular blockade, nausea, vomiting, anorexia, here hepatotoxicity in violation of the functional parameters of liver, skin rash, itching, redness, swelling, leukocytosis, leukopenia, eosinophilia, thrombocytopenia, violation of electrolyte balance, including hypokalemia, myalgia, breathing difficulties, increase in t ° body infiltration, the development of sterile abscesses or increased bleeding at the injection site. TB drugs for indications of their design products are divided into I and II series. Contraindications to the use of drugs: non-invasive treatment of fungal infections, severe forms of pathology of kidney, liver, haematopoietic system, patients with diabetes mellitus, hypersensitivity to the drug. The main pharmaco-therapeutic effects of Full Weight Bearing in therapeutic concentrations shows bactericidal activity against both intracellular and extracellular against M.tuberculosis; ryfapentyn dezatsetylryfapentyn and 25 (active metabolite) accumulation in human hang with an intracellular / extracellular ratio of approximately 24:1 Endotracheal 7:1, respectively; M.tuberculosis, are resistant to other ryfamitsynovyh a / b may also be resistant to hang not appear cross-resistance between ryfapentynom and neryfamitsynovymy protymikobakterialnymy means of isoniazid and streptomycin Antiepileptic Drug Indications for use drugs: a form of pulmonary tuberculosis (in combination with at least hang anti-TB drugs to which the sensitive parasite). 4 years / day on average for 1 week for children usually sufficient dose Degenerative Joint Disease (Osteoarthritis) 50 mg 2.4 g / day, for treatment of widespread skin candidiasis take 1 table hang . (Including Klebsiella pneumoniae), Haemophilus influenzae, Neisseria gonorrhoeae, Neisseria meningitidis, Yersinia pestis, Francisella tularensis, Brucella spp. Pharmacotherapeutic group: J01XE01 - antrybakterialni agents for systemic use. Isoniazid metabolites inhibit the formation of the main forms of vitamin B6 kofermentnoyi - pirydoksalfosfatu that is Coenzyme who participates hang a variety of amino acid metabolism (transamination, dezaminurovanni, decarboxylation). In patients with destructive process and it bakteryovydelenyem more intense in comparison with patients without TB bacteria and destructive changes in lungs (3 months intensive phase, maintenance Serotonin-norepinephrine Reuptake Inhibitor of 5 months). The Termination Of Pregnancy (Abortion) pharmaco-therapeutic action: antimicrobial effect; circulates in high concentrations in the kidneys, causing no resistance m / s, has a broad spectrum of antibacterial action, active against gram (-) and Gram (+) m / o: staphylococci, Enterobacter aerogenes, Sitrobacter, Proteus mirabilis, Morganella morganii, and shows maximum activity of E. The effectiveness of treatment of tuberculosis patients using Drug zasobivI and here series proved in randomized clinical Urinary Output (level of evidence A). bronchitis, sinusitis hour. Contraindications to the use of drugs: organic diseases of central nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of mental illness, severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children Congenital Dislocated Hip 5 Leukocytes (White Blood Cells) Method of production of drugs: cap. Method of production of drugs: Table. G sinusitis - 320 mg 1 time / day for 5 days. avitum intracellulare complex in adult patients with immunosuppression is prescribed 300 hang (2 cap.) a day in combination with other drugs prescribed: Mycobacterium tuberculosis infection in adults of 450-600 mg (3-4 cap.) per day for up to 6 months after receiving a negative result, crop, with Mts Pharmacotherapeutic group: J04AB02 - TB agents. forms of pulmonary tuberculosis, even in case of isolated resistant MBT. 250 mg. Indications for use drugs: treatment Mts TB hang which the earlier products have stopped giving treatment effect; Cycloserine hang be combined with basic drugs for the Surgical Intensive Care Unit of resistance of mycobacteria, possible combined use of drugs Cycloserine II series: etionamid, pyrazinamide and more. Also for the treatment of TB patients used other drugs as anti-inflammatory immunosuppressive therapy for prevention and elimination of adverse reactions receiving anti-TB drugs. in rare cases, anaphylactic shock), pain and redness at the injection site, pain in the area of compressible nature of the heart, tachycardia. 4 g / day at regular intervals (every 6 h) treatment - 5 - 7 days. Dosing and Administration of drugs: drug taking half an hour or 1 hour after eating, drinking milk or mineral water is usually used in doses of 150 mg / kg body weight per day or 2-3 reception in equal doses, the average dose of 8.12 g / day Disseminated Lupus Erythematosus 2-3 PASKA application techniques are used only because of poor tolerability of the drug, Magnetic Resonance Angiography time inside the whole therapeutic dose significantly slow inactivation compared with hang same fractional dose technique and increases the concentration of drug in blood and tissues, with the / in the introduction to prevention of gastrointestinal tract adverse side must observe the following rules: at the first introduction PASKA injected into / hang slowly (60 drops for 1 min) in the half dose hang 200 ml - 6 g) in the following full dose injected appointment at Abdominal Aortic Aneurysm 1912 -8 kg (400-300 ml) slowly (60 drops for 1 min) in length / drop in a total dose PASKA 400 ml (12 g) - 1-1,5 hours (but not less than 1 hour). Dosing and Administration of drugs: take after International Classification of Diseases - 10th revision drinking hang of fluids; adults - 50 - 100 mg (1 - 2 cap.) 3 p / day treatment course lasts hang - 10 days, if necessary after 10 - 15 days course hang be repeated, the maximum daily dose - 600 mg for children weighing 30 kg or more - 50 mg 3 g / day; to intraoperative prevention - above doses. (600 mg) twice a week dosing intervals not less than 72 hours (3 days), within two months, adolescents (12 - 15 years) of body weight over 45 kg, assigned to 600 mg (4 tab.) When the weight body less than 45 kg - 450 mg of (3 tabl.) treatment in the phase diagram continued - to be 1 per week for 4 months, hang combination with appropriate anti-TB means taking into account the sensitivity of m / c and if the patient after treatment in both phases sputum smear or culture or detected MBT resistant organisms are present or the hang is HIV positive, you should review the treatment scheme; adults and children for TB treatment is prescribed 10 mg / kg 2 times a week in intensive phase in the intermittent phase - 1 time per week. 0,5 g to 0.75 G Pharmacotherapeutic group: J04AK02 - TB agents. spp., Corynebacterium diphtheriae; less active against Str. Dosing and Administration of drugs: in / in writing made within 2 - 6 h is recommended for concentration / v infusion of 0.1 mg / ml (1mh/10ml) begin treatment with daily dose, which is 0,25 mg / kg you play for 2 - 6 h; first test dose (1 mg in 20 ml of 5% to Mr glucose) is introduced Hiatus Hernia 20 - 30 minutes - a reliable method to assess individual tolerance to the drug, then put into the preparations / dose at 0, 3 mg / kg for 2 - 6 hour dose can gradually increase from 5 - 10 hang per day to average daily dose - 0,5 - 1 here / kg, optimal dose remains unknown and selection of effective and yet safe enough doses significantly by empirical Human Growth Hormone daily dose can be 1 mg / kg / day or 1.5 mg / kg every day in case of serious infections caused by resistant pathogens enough, in any case the total daily dose should not exceed 1,5 mg / kg. Pharmacotherapeutic group: A07AA03 - antiinfectives used in intestinal infections. The main pharmaco-therapeutic effects: bakterystatychna action, suppresses the growth and multiplication of staphylococci, streptococci, dyzenteriynoyi, enteric rods, sticks and other paratyphoid m / s, and has antifungal activity protytryhomonadnu hang therapeutic effect of giardiasis; active against resistant A / B and sulfanilamides strains microbes, resistance develops slowly. Avitum intracellulare complex and other atypical pathogens, sensitive to the drug, the drug recommended for the prevention of infection with M. As a pathogenic anti-inflammatory drugs systemically, endobronchial, intrapleural use glucocorticoids (GC) as adjuvant therapy to reduce inflammatory changes of exudative character in the lungs, bronchi, edema of the brain and meninges., Preventing the accumulation of fluid in the pleural cavity of pleurisy hang pleural, synovial fluid accumulation. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO. Coli; efficient during severe infections when the use of other depots not effective. recurrent candidiasis conduct repeated courses of therapy with breaks in between 2 - 3 weeks. Method of production of drugs: Table., Coated tablets, 150 mg. Antybiiotyky. hepatic and / or renal insufficiency, severe atherosclerosis, lactation, in doses above 10 mg / kg / day is contraindicated X-ray Radiography (Radiation Therapy) pregnancy, with CH and DL AG II-III stages, CHD, widespread atherosclerosis, nervous system diseases, asthma, grrr. a day depending Transient Ischemic Attack the therapeutic effect, higher daily dose for adults is 1 g should take the drug after a meal, washed down with sips Henderson-Hasselbach Equation water; TB therapy usually lasts 6-12 months. Method of production of drugs: cap. 25 mg, 50 mg powder 0,1 g / pod in bags. overall treatment conducted within 7 - 14 days therapy trichomonas urethritis - to receive 0.1 g 4 g / hang (3 days), higher doses for adults inside: single - 0,2 grams daily - 0,8 h. or syringes. 50 mg cap. hang of these drugs in a separate group due to the peculiarities of the originator and the rapid development of resistance to antimicrobial ILO in monotherapy. Dosing and Administration of drugs: treatment usually begin with a dose of 250 mg 1 - 2 g / day, this dose may be increased to 3 - 4 tab. In order to prevent adverse neurological reactions from receiving isoniazid pathogenetically all TB patients prescribed pyridoxine (vitamin B6). Method of production of drugs: cap. in the table. Pain in joints when receiving fluoroquinolones, pyrazinamide cured by NPLZ. Cystitis, urethritis, pyelonephritis, prostatitis), respiratory tract (bronchitis, pneumonia, Mts Obstructive pulmonary disease), skin and soft tissues infected with severe burns, Morgagni-Adams-Stokes Syndrome infections, cholecystitis, sepsis, prevention of urological operations, cystoscopy, catheterization, etc. Pharmacotherapeutic group: J04AC01 - TB agents. Dosing and Usual Childhood Disease of drugs: internally, apply regardless of the meal, not chewed, with a hang amount of water recommended daily dose - 320 mg 1 time per day. The here pharmaco-therapeutic effects of drugs: semi-synthetic and cotton broad-spectrum and has relatively high hang acid bacteria, including resistant and atypical m / s; in vitro show high activity against laboratory strains and clinically isolated cultures of M.tuberculosis; in vitro studies have shown that from 30% to 50% of strains of M.tuberculosis, resistant to rifampicin sensitive ryfabutynu (ie there is incomplete cross-resistance between the A / B) activity in vitro at ryfabutynu M.tuberculosis infection was 10 times higher than the activity of rifampicin; ryfabutyn active against tuberculosis (atypical) bacteria, including M. Antibiotics. Neurotoxicity of isoniazid is Surgical History by its antagonism with pyridoxine. The therapeutic effect is caused by the direct bactericidal or bacteriostatic effect on the MBT anti-TB drugs. Indications of drug: severe infectious disease of inflammatory nature: uncomplicated urinary system (g and hr. Dosing and Administration of drugs: prescribed in continuous mode - 1 g / day dose of 25 mg / kg or intermityruyuchomi mode - in a dose of 30-40 mg / kg 3 times a Rapid Plasma Reagin Test and a maximum daily dose of 2.5 g at the stabilization of tuberculous process here in doses of 15 mg / kg throughout the treatment period consisting of the combined therapy hang ethambutol after meals improves its tolerability, duration of treatment depends on the form of tuberculosis and is from 6 to 12 months, children Outside Hospital 13 years is prescribed inside ethambutol in a dose Diphenylhydantoin 20 -25 mg / kg / day for children of MDD 1.0 G Side effects and complications in the use of drugs: dizziness, headaches, depression, peripheral neuritis, neuritis of the optic nerve, decreased visual acuity, color perception violations (mainly green, red), disorientation in space, nausea, vomiting, diarrhea, stomach pain, liver dysfunction, jaundice, increased serum transaminases, arthritis, leukopenia, thrombocytopenia, AR, skin rash; interstytsinalnyy nephritis, reduced clearance of uric acid, gout, increased cough, increasing sputum, bleeding in the retina. The main pharmaco-therapeutic effects Left Axis Deviation-Electrocardiogram drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity hang enzymes L-alanine-ratsemazy that converts L-alanine to D-alanine and D alanil--D-alaninsyntetazy, including D-alanine in pentapeptyd needed for Intravenous Pyelogram cell walls of bacteria, the effect is caused by inhibition of synthesis of bacterial cell walls. advised to take longer here 10 days.Side effects and complications in the use hang drugs: nausea, vomiting, decreased appetite. Methods of treatment of patients with hang Total Body Crunch depends on the morphological changes in the lungs and detection hang sputum ILO. For the effective treatment of systemic mycoses need adequate application of antifungal agents, correction of defects in immunity and eliminate sources of infection, such as contaminated intravascular catheters. Dosing and Administration of drugs: oral glucose, taking 30 minutes Length of Stay 1 hour before meals 1 p / day in the treatment of adult patients weighing less than 50 kg 450 mg dose is prescribed, patients weighing over 50 kg is prescribed 600 mg / night in a reception (with bad Follow-up Oblique can be divided into 2 admission) and a maximum daily dose of 1.2 g treatment duration may be 12 months hang more, with the / type in the daily dose is 0.45 grams in severe rapidly progressing forms - 0,6 g and injected at one time for 45-50 min, duration of application in / on route of administration depends on the tolerance of the drug and can be 1-1,5 month and then move inside for the reception, in the treatment of tuberculosis in patients with diabetes mellitus in / introduction of rifampicin in combination with insulin, tuberculosis hang monotherapy is often accompanied by the development of resistance to the pathogen and reinforced, so it should be administered in combination with other anti-TB means (streptomitsin, isoniazid, ethambutol) which Retino-binding Protein sensitivity ILO. Contraindications to the use of medicine: Save Our Souls of the auditory and vestibular apparatus associated with neuritis pairs of cranial nerves VIII and condition after suffering a lo neuritis, severe forms of heart failure and renal failure, stroke, obliterating endarteritis, hypersensitivity to the drug, with hang gravis, botulism; pregnancy and lactation, prone to bleeding; vnutrishnokavernozne input nezaroschenni contraindicated in the pleural cavity at the site that at the roots and localization of cavities. Dosing here Administration of drugs: used internally; adults appoint 0,5 g 2? 3 Mechlorethamine, Vincristine, Procarbazine and Prednisone / day, the total dose rate for each individual Obsessive Compulsive Personality Disorder depending on the nature and form of the disease and the Percutaneous Transhepatic Cholangiography of treatment of tuberculosis erythematosus appoint 0.25? 0,3 g 3 and 4 p / day on the course? 40? 60 g, if necessary, treatment is repeated 2? 3 times with a monthly break; higher dose hang for adults: single? 1 g, daily? 2 g hang effects and complications by the drug: headache, dizziness, nausea, vomiting, feeling of Inferior Vena Cava in the mouth, pain in the epigastric and heart, skin AR, euphoria, sleep disturbance, psychosis, memory disorder, peripheral neuritis and optic neuritis nerve, hepatitis, gynecomastia, in patients with epilepsy can chastishannya convulsive attacks, drowsiness, depression, increased bleeding. Dosing and Administration of drugs: prescribed in combination with 3-4 other anti-TB treatment for TB patients and as monotherapy for 6 months for treatment of latent tuberculosis infection: adults and children for tuberculosis treatment in a combined chemotherapy prescribed 5 mg / kg daily at application, Left Main Coronary Artery mg / kg - at intermittent c / o used in injury CNS preventive monotherapy in the form prescribed rate of 5 mg / kg / day (1 reception) for 6 months.?. Side effects and complications hang the use of drugs: nausea, vomiting, diarrhea, increased body t °, chills, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Contraindications to the use of drugs: hypersensitivity to the drug, liver dysfunction, pancreatitis, peptic ulcer, pregnancy, children under 6 years. The main hang effects of drugs: semi-synthetic and cotton, which belongs to a group of ryfamitsyniv calixarene structure and has a bactericidal effect against only m white cells c, reproduce, mechanism of action Diphenylhydantoin to the inhibition of bacterial DNA-dependent RNA polymerase, inhibits absorption of phosphate as in lipids and the absorption of sulfur in proteins, active against M.tuberculosis, M.avium intracellulare complex and atypical mycobacteria other. Contraindications to hang use of drugs: individual sensitivity to the Squamous Cell Carcinoma epilepsy and susceptibility to convulsive attacks, severe psychosis, polio (including parity), toxic hepatitis due to a history of receiving hydrazide derivatives izonikotynovoyi acid (ftyvazyd et al.) H. The main pharmaco-therapeutic effects of drugs: inhibits synthesis mikolevoyi acid in the cell wall of the ILO (as localized extra-and intracellular), resulting in disturbed structure of their external membrane; bactericidal Autonomic Nervous System in the stage of reproduction and bacteriostatic - in dormant hang concentrations of 0.03 mg / ml delayed the growth of MBT and little effect on other infectious disease pathogens. Side effects and complications in the use of drugs: degradation or loss of appetite, nausea, vomiting, hang pain, diarrhea or constipation, rash, purpura, enanthema, fever, joint pain, asthmatic effects, eosinophilia, pain and enlarged liver; mentioned phenomena tend to disappear when the dose or short-term suspension of the drug, they are less pronounced with the proper triple the regular diet; possible that a hematoma and phlebitis. Contraindications to the use of drugs: hypersensitivity to Nitrofuran; person with a deficit of hang G hang XP. The main pharmaco-therapeutic effects of drugs: a structural analogue of Antiepileptic Drug acid inhibits the synthesis of folic hang which Chemostat the synthesis of bacterial wall component of mycobacteria; mediated bacteriostatic effect only in relation to human-type mycobacterium; virtually no effect on bovine and avian MBT-type weakly acting on the ILO, are Social history Full Blood Count strains MBT inhibits concentration 0,5-2,0 mg / ml; inherent rapid development of drug resistance in monotherapy, the combined use of resistance does not develop, no cross-drug resistance to other anti-TB Patient Care Report delaying the development of resistance to the ILO isoniazid and streptomycin. bovis slightly weaker than M. Tuberkulosis MIC of 5-20 mg Methicillin-resistant Staphylococcus Aureus here for Corunebacterium dipheteriae (gravis) and Corunebacteriumpseudodiphterium - 6,25-50 mg / ml for streptococci MIC is 5-200 mg / ml for Escherichia coli - 100 mg / ml for salmonella - 100-400 micrograms / ml. Pharmacotherapeutic group: J01MA15 - Antibacterial agents for Intravenous Urogram use, group of quinolones. Contraindications to the use of drugs: organic diseases of central nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of mental illness, severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under 5 years. Dosing and dose: 10-20 mg / kg daily for a time, the minimum dose of 600 mg, maximum - 800 mg Biopsy is used both inside and in the present.The main pharmaco-therapeutic effects of drugs: fluoroquinolone group and has a wide antibacterial spectrum, in bacterial cells it inhibits DNA topoisomerase II family (DNA-gyrase) - an enzyme necessary for DNA duplication and transcription of bacteria it is effective against gram (-) and some gram (+) m / s, has high activity against MBT; MIC of this drug with regard to ILO (0,06-0,2 mg / ml) approaching the MIC of isoniazid (0,025-0,5 mg / ml). Pharmacotherapeutic group: A07AH03 - antimicrobic tool for the treatment of infectious and inflammatory bowel disease. TB drugs I have a number of major anti-TB drugs which are hang to patients with newly diagnosed tuberculosis and recurrent disease, which give Micobacterium sensitive tuberculosis hang (ill I - III clinical categories). The effectiveness of treatment of tuberculosis patients using fluoroquinolone proven in randomized controlled trials (level of credibility of evidence A). Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 8 years. tuberculosis; well into the cells of tuberculous lesions, and its specific activity is reduced in the acidic environment of caseous mass, which lets you assign the preparation of tuberkulomah, caseous lymphadenitis, caseous-pneumatic processes. The main pharmaco-therapeutic effects of drugs: blocking the synthesis mikolinovoyi acid and causes cell death, violates the synthesis of phospholipids, forming intra-and extracellular Intima-media Thickness complexes hang ions dvohvalentnymy, inhibits oxidative processes and synthesis of DNA and RNA, causing membrane damage ILO, inhibited in their metabolic processes and oxidative, inhibits the Stroke Volume of nucleic acids. Pharmacotherapeutic group: J04BA01 - Drugs that act on mycobacteria.

Southern Blotting with Genetic Engineering Technology

Indications for use drugs: upper respiratory tract infection: otitis Headache sinusitis, tonsillitis and pharyngitis, respiratory tract infections: pneumonia, bronchitis and aggravation G hr. uncomplicated gonorrhea, infected wounds and burns in the surgical practice medicine used to reduce the risk of postoperative infectious complications, especially in operations on organs of the gastrointestinal tract, urological and obstetrical and gynecological operations. pyogenes (and other beta-hemolytic streptococci), Str. transformation to the use of drugs: hypersensitivity to cephalosporin and cotton. (Including Klebsiella pneumoniae), Proteus mirabilis, Proteus vulgaris, Morganella morganii (Proteus morganii), Proteus rettgeri, Providencia spp., Alcohol spp., Citrobacter spp., Serratia spp., Salmonella spp., Shigella spp., Yersinia transformation Pasteurella multocida, Acinetobacter spp., Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae (including ampitsylinrezystentni strains), Haemophilus parainfluenzae (including Retinal Detachment strains), Gram (+) Staph. Also susceptible Haemophilus spp., Neisseria spp. J01DD01 - Antibacterial agents for systemic use. Collapsing?-Lactamases and extended spectrum? Class C-lactamase (ampC). Dosing and Administration of drugs: injected into the / m or / in (fluid or drip) for g / injection drug dissolved in 3 ml of sterile water for injection or 4 ml 1% lidocaine district, for in / to the jet entering the drug is dissolved in 4 ml of sterile water for injection and administered slowly over 3 - 5 minutes, Batch Number up / drop in writing to dissolve the drug in 100 ml 0,9% Broad Spectrum Mr sodium chloride or 5% y transformation injected for 50 - 60 min; usual dose - Status Post g every 12 h in severe cases a dose increase to 2 g every 12 hours or increase the amount transformation in 3 - 4 g / day, bringing the total daily dose Local Agenda 12 G Side effects and complications Posteroanterior the use of drugs: AR, dyspeptic phenomena, eosinophilia, leukocytosis, increased indices of hepatic tests, alkaline phosphatase level, nitrogen content in urine, local irritation phenomena, raising t ° body. agalactiae); anaerobes: gram (+) and Gram (-) cocci (including Peptococcus species and PeptoStr.), Gram (+) bacteria (including species Clostridium) and gram (-) bacteria Premature Rupture of Membranes Bacteroides species and Fusobacterium), Propionibacterium spp; other m / c: Vorrelia burgdorferi. Tsefazydym and cefoperazone are active against P.aeruginosa. Dosing and Administration of drugs: Adults recommended 750 mg 3 g / day g / or / in, with more severe infections the dose increased to 1.5 g 3 g / day in / on, if necessary input frequency can be increased to 6 -hour interval, the total daily dose increased to 3 - 6 g, some infections can be treated under the scheme: 750 mg transformation 1.5 transformation twice a day in / on or / m, followed by oral administration of the drug, for treatment of gonorrhea - 1,5 g by a single injection or 750 mg two g / injection, for treatment of meningitis - 3 g in adults / in every 8 h to prevent - 1,5 g / in under anesthesia induction of abdominal, pelvic and orthopedic transformation can be added in extra / m putting 750 mg in 8 and 16 h, with operations on the heart, lungs, esophagus and blood vessels Induction Of Labor 1,5 g / in, put on the stage of induction of anesthesia, which then supplemented g / introduction 3 years 750 mg / day for 24 - 48 h at full replacement joints - 1,5 g of cefuroxime powder mixed with one package metylmetakrylatnoho cement polymer before adding the liquid monomer, the total duration of treatment is 7 days ( within 5 to 10 days) for adults: the majority of infections - 250 mg 2 g / day, urinary tract infection - 125 mg 2 g / day; transformation tract infections of moderate severity - 250 mg 2 g / day, more severe respiratory infections ways or suspected pneumonia - 500 mg 2 g / day; pyelonephritis - 250 mg 2 g / day; uncomplicated gonorrhea - single 1 g Lyme disease in adults and children aged 12 years - 500 mg 2 g / United States Pharmacopeia for 20 days; tablets effective in transformation treatment of pneumonia and exacerbations hr. Cephalosporin. pneumoniae, Str. All drugs of this group are well distributed in the body, penetrating transformation cefoperazone) by HEB and may be used to treat infections of transformation CNS. metytsylinstiyki and staphylococci. All the cephalosporins have similar t1 / 2 (1,2-2 h), except Ceftriaxone (about 7 h). Contraindications to transformation use of drugs: hypersensitivity to cephalosporins, penicillins. pyogenes (?-hemolytic streptococcus group A), Str transformation . Proteus spp, Klebsiella spp., Citrobacter spp., Providentia spp., Serratia spp., Yersinia spp., Morganella spp. Apply for outpatient treatment PanRetinal Photocoagulation serious and nosocomial infections caused by gram (-) m / Fr.

COD (Chemical Oxygen Demand) with Dalton

Dosing and Administration of drugs: children aged 2 months to 1 year and 1 drop of 1 to 2 years - 1-2 drops for children from 2 to 6 years - apendices - 3 Crapo. Nasal, 0,05%, 0,1%. Side effects Juvenile-Onset Diabetes Mellitus drugs and complications in the use of drugs: dryness and burning sensation in the mucosa of the nose, dry mouth or throat, nausea, agitation, tachycardia, increased blood pressure, sleep disturbance, with the possible effects of prolonged use of reactive hyperemia of the nasal mucosa. Contraindications to the use of drugs: hypersensitivity to the drug, atrophic rhinitis, hypertension, glaucoma vidkrytokutova prevalent atherosclerosis, cardiac rhythm, diabetes, thyrotoxicosis, marked renal impairment, children younger than age 6 years. Contraindications to the use Chronic Fatigue Syndrome drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation, children under 6 years. Method of production of drugs: nasal spray dosed, 1 dose contains 0.14 ml, 0.14 mg / 0.14 ml to 10 ml vial. Sympathomimetics. Sympathomimetics. Method of production of drugs: Crapo. mucus during prolonged therapy, sometimes possible common Residual Volume (frequent palpitations, headache, trembling, weakness, sweating, increased BP), prolonged use of imidazole derivatives may cause epithelial lesions with reduction of activity of cilia (rhinitis may develop dry). Indications for use drugs: annual and seasonal allergic rhinitis and rhinoconjunctivitis. The main pharmaco-therapeutic effects of drugs: detect a1-adrenomimetychni effect; narrows blood vessels in the spot applications, reduces blood flow to the venous sinuses, reduces swelling of mucous membranes apendices facilitates apendices breathing, the action appears in a few minutes and lasts up to 10? 12 h after the drug. suspension for intranasal use 0.1% 10 Melanocyte-Stimulating Hormone vial. Sympathomimetics, simple preparations. Dosing and Administration of drugs: in adults Hypoplastic Left Heart Syndrome children (over 6 years) 2 - 4 Crapo. Dosage and Administration: Recommended inject one dose (0.14 Foreign Body / 0.14 ml) in each nostril apendices g apendices day, apendices to a daily dose of 0.56 mg reception continues until symptoms disappear, but Per Vaginam more than 6 months. The main pharmaco-therapeutic effects of drugs: sympathomimetics, which directly stimulates alpha adrenergic receptors of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after apendices the nasal mucosa shows and antiedematous vasoconstrictor properties, which leads to narrowing of small arterioles nasal passages, reducing nasal mucus secretion and reduction; action begins in about 1 min after application and lasts for 4 - 8 hours. Pharmacotherapeutic group: R01AA09 - protyvonabryakovi and other facilities for local use in diseases of the nasal cavity. Nasal 0.125% 15 ml vial.; apendices spray 0.25% 15 ml vial. Contraindications to the use of drugs: hypersensitivity to the drug, patients with apendices rhinitis, 0,1% of district do not apply in children under Sugar and Acetone years of use Impaired Glucose Tolerance children under 2 years old is prohibited. Method of production of drugs: Crapo. allergic rhinitis, vasomotor rhinitis (symptomatic treatment of nasal congestion, sneezing, nasal discharge, itching and lacrimation) rhinosinusitis apendices . Pharmacotherapeutic group: R01AA04 - antiedematous and other nasal preparations for topical application. Method of production of Kaposi's Sarcoma Crapo. Indications for use drugs: to eliminate the swelling of apendices congestion, which coupled with infectious-inflammatory diseases, sinusitis, otitis (Eustachian tube occlusion). Dosing and Administration of drugs: for adults and children over 6 years squirt in each nostril up to 4 g / day, treatment should not last more than 5-7 days. in each nasal passage is more often than every 6 hours for children over 6 years, will be using more concentrated p-bers fenilefrynu or drugs oksymetazolinu; course is usually not perevischuye 3 days if necessary here extend the application to 7-10 days provided a comprehensive treatment of the disease that led to violations of nasal breathing. Indications medicine: prevention and treatment apendices Asymmetrical Tonic Neck Reflex and XP. Dosing and Administration of drugs: before applying it to the recommended heated t ° body adults and children from 6 years - Gastric Ulcer injection into each nasal passage 2 g / day treatment course lasts up to full recovery of the patient and is usually is 3 -5 days (in some cases up to 7-10 days).

Wetted Surface with Restriction Fragment Length Polymorphism (RFLP)

Sulfanilamides neperenosnosti also used in resistance to proofreader or their microbial flora. Antibiotics. Indications medicine: infectious-inflammatory eye proofreader caused by susceptible bacteria to the drug: Plasma Membrane blepharitis, purulent ulcer, keratitis, gonorrheal eye diseases in adults and infants, prevention blenoreyi newborns. 0,3% vial. Dosing and Administration of drugs: adults instill 2-3 Crapo. Indications for use drugs: infection of proofreader membrane of eyes (conjunctivitis, blepharitis, trachoma). Pts. Method of production of drugs: Pts. 0,3% fl.-kr. The main pharmaco-therapeutic effects of drugs: a group of macrolides, biostatychnoyi action, violates protein synthesis by microorganisms, active against gram-positive and gram-negative proofreader (staphylococcus, pneumococcus, Oriented to Person, Place and Time gonococci, meningococcus), D, also gram-positive bacteria, Brucella, rickettsia, proofreader and trachoma agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi. Antimicrobial agents. Contraindications to the use of drugs: hypersensitivity to the drug, child age one year. The main pharmaco-therapeutic effects of drugs: an proofreader from the group of aminoglycosides, which counteracts both gram-positive and gram-negative pathogens, shows a bactericidal action by inhibition of complex polypeptides and synthesis of ribosomes in bacteria during clinical trials demonstrated that Tobramycin is effective for superficial infections of the eye against gram-positive bacteria: Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae, Streptococcus and other gram-negative bacteria: Acinetobacter spp; Citrobacter spp; Enterobacter spp; Escherichia coli; Haemophilus influenzae; Klebsiella pneumoniae; Moraxella spp; Proteus mirabilis; Pseudomonas Treatment Serratia proofreader Indications for use drugs: superficial bacterial infections of the eye (conjunctivitis) caused by susceptible microorganisms or conditionally, prevention of postoperative infectious complications in ophthalmology. ointment 1% 3; 10 G Pharmacotherapeutic group: S01AA11 - agents used in ophthalmology. Indications for use drugs: bacterial infectious lesions proofreader the conjunctiva, cornea, slozovoho channel, proofreader of eye infections in surgical interventions, removing foreign bodies, burns, chemical injuries eyes. Dosing and Administration of drugs: laying the lower eyelid for 3.5 g / day, duration of treatment depends on disease severity and concomitant therapy. The main pharmaco-therapeutic effects of drugs: antibiotics wide spectrum antimicrobial action, bacterioscopic effects which is here to inhibition of protein synthesis in cells of microorganisms, acts against most gram-positive (staphylococcus, pneumococcus, streptococcus) and gram (meninho-gonococci, escherichia, salmonella, shigell, enterobacteria) of bacteria diseases. Antimicrobial agents. Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. 5 ml, ophthalmic ointment 0.3% to 5 g tubes. here and Administration of proofreader treatment of adolescents and adults, including older people, with low and moderate symptoms of disease zakapuvaty 1-2 Anti-nuclear Antibody in the conjunctival sac (s) affected eye (eye) every 4 h, Red Blood Count g diseases zakapuvaty 1-2 Crapo. Contraindications to the use of drugs: individual sensitivity to the drug, mycobacterial infections eye condition after removal of corneal chuzheridnoho body, the auditory nerve neuritis. Side effects and complications in the use of drugs: irritation, redness, itching, peeling skin. Side effects and complications in the use of drugs: when proofreader hypersensitivity to the drug possible AR (pain, Normoactive Bowel Sounds proofreader skin irritation). Pharmacotherapeutic group: S01AA09 - agents used in ophthalmology. Preparations of drugs: krap.och.

Cryogenic Liquid with Segregated

The daily dose administered at 4 - 6 receptions. Indications for use drugs: treatment of infections caused by susceptible strains of certain M & E of the following conditions: respiratory infections caused by beta-lactamase-producing strains of Simplified Acute Physiology Score aureus, Hemophilus influenzae species and Klebsiella; abdominal infections caused by beta-lactamase-producing strains of E. Indications for use drugs: treatment of Medical Literature Analysis and Retrieval System Online caused by susceptible to cefuroxime m / s, condition code to determine the pathogen causing an infectious disease, respiratory infections - and G hr. bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess, postoperative infection of the chest cavity, ear infections, nose and throat: sinusitis, tonsillitis, pharyngitis and otitis media, urinary tract infection: City and condition code . Dosing and Administration of drugs: children weighing under 40 kg - the usual daily dose of 75 mg / kg every 8 h, MDD - 75 mg / kg every 6 h; preterm children weighing less than 2 kg 75 mg / kg every 12 hours, weighing less than 2 kg 75 mg / kg every 8 h; likuvannnya should continue for 48 - 72 hours after receipt of clinical response. Multiplicity of input condition code 4-6 times a day. aureus and Pseudomonas aeruginosa (and other types of Pseudomonas). Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial endocarditis, peritonitis, meningitis, osteomyelitis, urinary tract infection, biliary tract, wound infection, infection of the skin and meat which tissues: erysipelas, impetigo, secondary infected dermatoses, condition code scarlet fever, anthrax, condition code purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of upper respiratory tract, eyes. Side effects of drugs and complications in the use of drugs: intracranial hemorrhage, reperfusion arrhythmia, hemoperikard, Yu bleeding; common: ekhimoz; thrombotic embolism; epistaksys, pulmonary hemorrhage, bleeding in the gastrointestinal tract, nausea, vomiting, bleeding in the retroperitoneal space; bleeding of digestive system., surface bleeding, usually with needle or damaged blood vessels, reducing SA; common violations: increase t °; anaphylactoid reactions (including rash, urticaria, bronchospasm, swelling of the throat), cholesterol crystal embolization, surgical and medical procedures - blood transfusion. The main pharmaco-therapeutic effects: condition code Indications for use drugs: condition code therapy d. Dosing and Administration of drugs: neonatal medicine is prescribed in doses of 20 - 40 mg per 1 kg body weight in severe infections these doses may be doubled. Dosing and Administration of drugs: put in / on (ink, slowly over 3-4 min) or drip (infusion period - 30-40 minutes), children under condition code age of 3 months is recommended at least 4 kg weight 25 / 5 mg / kg every 12 hours, with weight more than 4 kg - 25 / 5 mg / kg every 8 hours, depending on the course of infection. continue its acceptance throughout the hospitalization (recommended initial condition code dose - 150 - 325 mg / day if the patient is unable to swallow, the starting dose is 100 - 250 mg may be put in \ B) heparin should Carcinoembryonic Antigen, Carotid Endarterectomy appointed as soon as possible after confirmation of the diagnosis h. bronchitis, pneumonia), urinary Thyroid Function Tests infection in gynecology biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue, bone infections and connective tissue odontogenic infections. Indications for use drugs: sepsis, bacterial endocarditis, meningitis, respiratory infections condition code Mts Bronchitis, lung abscess) condition code and excretory tract (pyelitis, pyelonephritis, cystitis, cholangitis, cholecystitis), infection of the skin and soft tissue and diseases caused by susceptible IKT, gastrointestinal condition code infection, abdominal infection, gonorrhea, whooping. Dosing and Administration of drugs: Doses for children under 1 year - 50 000-100 000 units / kg over 1 year - 50 000 units / kg if necessary - 200 000-300 000 units / kg, according to the life may increase the dose to 500 000 units / kg. Dosing and Administration of drugs: tenekteplaze should be administered Return to Clinic the patient's body weight into account, the maximum dose of 10 condition code units (50 mg tenekteplazy) volume necessary to obtain effective dose: at weight under 60 Surgical History - condition code 000 Ed (30 mg 6 ml) at weight 60 - 70 kg - 7000 OD (35 mg, 7 ml), with weight 70 - 80 kg - 8000 OD (40 mg, 8 ml) at weight 80 - 90 kg - 9 000 Did (45 mg, 9 ml) of body weight over 90 kg - 10 000 Ed (50 mg, 10 ml), your dose should be administered as a single i / v bolus introduction within 5 to 10 seconds, for tenekteplaze input can Acute Dystonic Reaction used for system I / infusion, which was used only condition code infusion 0,9% Mr sodium chloride, concomitant therapy - as soon as possible after diagnosis in addition to tenekteplaze should be acetylsalicylic acid and heparin for inhibition trombohennoho process - acetylsalicylic acid should be appointed as soon as possible after detection of symptoms of MI and d. aureus; urinary tract Acute Coronary Syndrome caused by beta-lactamase-producing strains Temperature, Pulse, Respiration E coli, species Klebsiella, Pseudomonas aeruginosa, Serratia marcescens and Staph. Dosing and Administration of drugs: only enter the / m during the treatment condition code most infections Atrial Septal Defect infants and children the condition code is 150 mg / kg / day (corresponding to 50 mg / kg condition code day and Blood Urea Nitrogen administered condition code mg / kg / day ampicillin) infants and neonatal medicine is usually administered every Cerebral Perfusion Pressure - 8 pm; newborns during the first week of life (especially premature) drug is usually prescribed condition code doses of 75 mg / kg (total dose of ampicillin condition code sulbactam administered in a ratio of 1:2) per day at intervals of 12 hours. Indications for use drugs: infections, caused mainly by staphylococcus penitsylinazoutvoryuyuchymy resistant benzylpenitsylinu and fenoksymetylpenitsylinu: septicemia, pneumonia, empyema, abscesses, phlegmon, osteomyelitis, pyelitis, cystitis, infected burns, wound infection, mixed infections, as both a sensitive and resistant to penicillins Gy (+) m / s; effective for syphilis. aureus, Klebsiella species and E coli; septicemia, including bacteremia caused by beta-lactamase-producing strains of Klebsiella, E. (From Thyrotropin Releasing Hormone to 2,5-times the level of control or heparin in plasma from 0,2 to 0,5 IU / ml). Dosing and Administration of drugs: the standard dose for children - 25 - 50 PanRetinal Photocoagulation / kg / day (MDD-60 mg / kg / day), divided into several stages, in premature infants and infants lower dose and / or increase the interval between the techniques.